Antisense to human CD39 dysregulates immune metabolism in inflammatory bowel disease

/in
Zhang L, Cagle C, Nguyen DH, Gomes GS, Gromova B, Csizmadia E, Karimitar A, Lee GR, Chen G, Kokkotou E, Grossberg L, Jiang S, Cheifetz AS, Kota SK, Longhi MS. Antisense to human CD39 dysregulates immune metabolism in inflammatory bowel disease. Cellular Molecular Immunology. 2025 Jul;22(7):730-742. doi: 10.1038/s41423-025-01295-6. Epub 2025 May 26. [Article]